Allied Journal of Medical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Allied Journal of Medical Research (2025) Volume 9, Issue 4

Next-gen diagnostics: Ai, liquid biopsy, poc

Maria Silva*

Department of Diagnostic Imaging, University of São Paulo, São Paulo, Brazil

*Corresponding Author:
Maria Silva
Department of Diagnostic Imaging
University of São Paulo, São Paulo, Brazil.
E-mail: maria.silva@usp.br

Received : 01-Oct-2025, Manuscript No. aaajmr-305; Editor assigned : 03-Oct-2025, PreQC No. aaajmr-305(PQ); Reviewed : 23-Oct-2025, QC No aaajmr-305; Revised : 03-Nov-2025, Manuscript No. aaajmr-305(R); Published : 12-Nov-2025 , DOI : 10.35841/aaajmr-9.4.305

Citation: Silva M. Next-gen diagnostics: Ai, liquid biopsy, poc. aaajmr. 2025;09(04):305.

Visit for more related articles at Allied Journal of Medical Research

Introduction

The landscape of medical diagnostics is experiencing unprecedented transformation, marked by rapid technological innovations aimed at enhancing precision, accessibility, and efficiency across various medical disciplines. These advancements are critical for improving patient outcomes, from personalized medicine to infectious disease management and cancer detection. This article looks at how diagnostic techniques are evolving to support precision medicine, focusing on new methods that help tailor treatments to individual patients. It covers areas like genetic profiling, advanced imaging, and liquid biopsies, showing how these approaches are crucial for more accurate diagnoses and personalized care, particularly in fields like oncology and rare diseases [1].

This paper explores the latest developments in point-of-care diagnostic tools for infectious diseases. It highlights innovations in rapid, portable, and user-friendly devices that allow for quick diagnosis outside traditional lab settings, which is critical for timely treatment and outbreak management. The focus is on technologies like microfluidics and biosensors, improving accessibility and efficiency [2].

This review delves into the progress of liquid biopsy as a non-invasive diagnostic tool for early cancer detection and ongoing disease monitoring. It emphasizes the analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes, highlighting their potential to revolutionize cancer management by offering less invasive, more sensitive, and dynamic insights into tumor biology [3].

This article examines the rapidly expanding role of artificial intelligence in medical imaging, from improving diagnostic accuracy to enhancing workflow efficiency. It covers AI applications in various imaging modalities like MRI, CT, and X-ray, discussing how deep learning algorithms are being used for disease detection, segmentation, and prognosis prediction, while also addressing challenges in clinical integration [4].

This paper discusses the latest advancements in biosensor technology for disease diagnosis. It highlights how these devices, designed for rapid and sensitive detection of biomarkers, are transforming healthcare. The article covers various biosensor types, including electrochemical, optical, and mass-based sensors, and their applications in detecting pathogens, cancer markers, and other disease indicators, often with point-of-care potential [5].

This review explores the emerging field of microbiome diagnostics and its applications in disease management. It details how analyzing microbial communities in the human body can provide unique insights into various conditions, from gut disorders to autoimmune diseases and even cancer. The article discusses novel techniques for microbiome profiling and their potential to inform personalized diagnostic and therapeutic strategies [6].

This article delves into the transformative potential of CRISPR-based diagnostic technologies. It highlights how these gene-editing tools are being repurposed for rapid, sensitive, and specific detection of pathogens, genetic mutations, and biomarkers. The review emphasizes their adaptability for point-of-care settings and their promise in enhancing diagnostic capabilities for infectious diseases and genetic disorders [7].

This paper discusses the shift towards digital pathology in diagnostic practices. It covers how whole-slide imaging and computational analysis are improving diagnostic accuracy and efficiency, especially in complex cases like cancer. The article addresses the benefits, such as remote consultation and enhanced quantitative analysis, alongside the current challenges in implementation and data management [8].

This review highlights the profound impact of next-generation sequencing (NGS) on diagnostic microbiology and personalized medicine. It details how NGS enables comprehensive pathogen detection, identification of antibiotic resistance genes, and early diagnosis of infectious diseases with unprecedented resolution. The article emphasizes its role in surveillance, outbreak investigation, and in guiding targeted therapies [9].

This article reviews the latest clinical applications of optical coherence tomography (OCT), a non-invasive imaging technique providing high-resolution cross-sectional images of tissue. It covers its utility in various medical fields, particularly ophthalmology for retinal diseases, and cardiology for intravascular imaging. The paper discusses advancements that enhance imaging depth, speed, and functional capabilities, making OCT a crucial diagnostic tool [10].

These diverse advancements collectively underscore a significant shift towards more precise, personalized, and accessible diagnostic capabilities, promising to revolutionize healthcare delivery and disease management worldwide.

Conclusion

Diagnostic techniques are rapidly evolving, driven by advancements in precision medicine, which tailors treatments to individual patients through methods like genetic profiling and liquid biopsies. Point-of-care diagnostic tools are becoming crucial for infectious diseases, offering rapid, portable, and user-friendly devices leveraging microfluidics and biosensors for quick diagnoses outside traditional labs. Artificial Intelligence (AI) is transforming medical imaging by improving diagnostic accuracy and workflow efficiency across various modalities, utilizing deep learning for disease detection and prognosis. Furthermore, liquid biopsy is emerging as a non-invasive method for early cancer detection and monitoring, analyzing circulating tumor DNA, cells, and exosomes to offer dynamic insights into tumor biology. Biosensor technology also advances disease diagnosis with rapid and sensitive detection of biomarkers, covering electrochemical, optical, and mass-based sensors for pathogens and cancer markers. Microbiome diagnostics offers unique insights into conditions from gut disorders to cancer by analyzing microbial communities. CRISPR-based diagnostic tools are being repurposed for highly sensitive detection of pathogens and genetic mutations, suitable for point-of-care settings. Digital pathology improves diagnostic accuracy and efficiency through whole-slide imaging and computational analysis, particularly in oncology. Next-generation sequencing significantly impacts diagnostic microbiology and personalized medicine by enabling comprehensive pathogen detection and identification of antibiotic resistance. Finally, Optical Coherence Tomography (OCT) is a crucial non-invasive imaging tool, especially in ophthalmology and cardiology, providing high-resolution images and enhancing diagnostic capabilities.

References

  1. Tao C, Hui Z, Ming M. Advances in diagnostic techniques in the era of precision medicine. Front Med (Lausanne). 2023;10(N/A):1248068.

    2. Indexed at, Google Scholar, Crossref

  2. Sha G, Xin Z, Hui Z. Recent advances in point-of-care diagnostics for infectious diseases. Front Microbiol. 2022;13(N/A):995213.

    3. Indexed at, Google Scholar, Crossref

  3. Yang W, Ming L, Hui Z. Advances in liquid biopsy for early cancer diagnosis and monitoring. Cancer Lett. 2024;589(N/A):216742.

    4. Indexed at, Google Scholar, Crossref

  4. Je HL, Jae K, Young SC. Artificial intelligence in medical imaging: Current applications and future directions. Korean J Radiol. 2023;24(9):839-851.

    5. Indexed at, Google Scholar, Crossref

  5. Shikha S, Saurabh S, Akash K. Recent Advances in Biosensors for Disease Diagnosis. ACS Omega. 2022;7(41):36166-36178.

    6. Indexed at, Google Scholar, Crossref

  6. Miao S, Yu Y, Hao Z. The clinical application of microbiome in diagnosis and treatment. Clin Transl Med. 2023;13(6):e1337.

    7. Indexed at, Google Scholar, Crossref

  7. Haoran L, Yaowen Y, Yifeng C. CRISPR-based diagnostic tools: current applications and future prospects. Mil Med Res. 2024;11(1):28.

    8. Indexed at, Google Scholar, Crossref

  8. Ting Z, Ling C, Yang W. Digital pathology: applications, challenges, and future trends. Arch Pathol Lab Med. 2023;147(9):1070-1077.

    9. Indexed at, Google Scholar, Crossref

  9. Yang Z, Cheng D, Wei L. Next-generation sequencing for pathogen detection and disease diagnosis. Mil Med Res. 2021;8(1):31.

    10. Indexed at, Google Scholar, Crossref

  10. Peng H, Shujie D, Yong W. Optical coherence tomography: advances in clinical applications. J Biomed Opt. 2020;25(7):071004.

    11. Indexed at, Google Scholar, Crossref

Get the App